For: | Zhao HW, Zhang JL, Liu FQ, Yue ZD, Wang L, Zhang Y, Dong CB, Wang ZC. Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension. World J Gastroenterol 2024; 30(31): 3668-3679 [PMID: 39193001 DOI: 10.3748/wjg.v30.i31.3668] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i31/3668.htm |
Number | Citing Articles |
1 |
Aysun Yakut. Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway. World Journal of Gastroenterology 2024; 30(43): 4672-4676 doi: 10.3748/wjg.v30.i43.4672
|
2 |
Xiaotong Xu, Tong Zhu, Changyou Jing, Minjie Jiang, Yunlai Fu, Fang Xie, Qinghua Meng, Jianjun Li. Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1423780
|
3 |
Hong-Xuan Tong, Yang Ye. Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension. World Journal of Gastroenterology 2024; 30(45): 4855-4858 doi: 10.3748/wjg.v30.i45.4855
|
4 |
Qi-Rong Jiang, Da-Wu Zeng. Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications. World Journal of Gastroenterology 2025; 31(3): 100752 doi: 10.3748/wjg.v31.i3.100752
|
5 |
Lu Jiang, Jian-Gao Fan. Gut microbiota in gastrointestinal diseases: Insights and therapeutic strategies. World Journal of Gastroenterology 2024; 30(39): 4329-4332 doi: 10.3748/wjg.v30.i39.4329
|